A significant shift in the country's drug policy has happened, as the regulators permit the availability of psilocybin mushrooms for therapeutic applications. Before this, these substances were heavily restricted, but a increasing body of research suggests they potentially offer aid for psychological illnesses like PTSD. This development represents